| Sp transcription factor family and its role in cancer S Safe, M Abdelrahim European journal of cancer 41 (16), 2438-2448, 2005 | 634 | 2005 |
| The aryl hydrocarbon receptor mediates degradation of estrogen receptor α through activation of proteasomes M Wormke, M Stoner, B Saville, K Walker, M Abdelrahim, R Burghardt, ... Molecular and cellular biology, 2003 | 404 | 2003 |
| Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature N Abdel-Wahab, H Safa, A Abudayyeh, DH Johnson, VA Trinh, ... Journal for immunotherapy of cancer 7, 1-10, 2019 | 259 | 2019 |
| Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience O Mamlouk, U Selamet, S Machado, M Abdelrahim, WF Glass, ... Journal for immunotherapy of cancer 7, 1-13, 2019 | 252 | 2019 |
| Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells M Abdelrahim, R Smith III, R Burghardt, S Safe Cancer research 64 (18), 6740-6749, 2004 | 247 | 2004 |
| 3, 3′-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5 M Abdelrahim, K Newman, K Vanderlaag, I Samudio, S Safe Carcinogenesis 27 (4), 717-728, 2006 | 237 | 2006 |
| Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells M Abdelrahim, R Smith, S Safe Molecular pharmacology 63 (6), 1373-1381, 2003 | 231 | 2003 |
| Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation M Abdelrahim, CH Baker, JL Abbruzzese, S Safe Journal of the National Cancer Institute 98 (12), 855-868, 2006 | 213 | 2006 |
| Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins M Stoner, M Wormke, B Saville, I Samudio, C Qin, M Abdelrahim, S Safe Oncogene 23 (5), 1052-1063, 2004 | 195 | 2004 |
| Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor–dependent and nuclear receptor–independent pathways SD Cho, K Yoon, S Chintharlapalli, M Abdelrahim, P Lei, S Hamilton, ... Cancer research 67 (2), 674-683, 2007 | 187 | 2007 |
| 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor α M Abdelrahim, E Ariazi, K Kim, S Khan, R Barhoumi, R Burghardt, S Liu, ... Cancer research 66 (4), 2459-2467, 2006 | 174 | 2006 |
| Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth SO Lee, M Abdelrahim, K Yoon, S Chintharlapalli, S Papineni, K Kim, ... Cancer research 70 (17), 6824-6836, 2010 | 170 | 2010 |
| Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins M Abdelrahim, S Safe Molecular pharmacology 68 (2), 317-329, 2005 | 170 | 2005 |
| Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells M Abdelrahim, I Samudio, R Smith, R Burghardt, S Safe Journal of Biological Chemistry 277 (32), 28815-28822, 2002 | 155 | 2002 |
| Oncogenic microRNA‐27a is a target for anticancer agent methyl 2‐cyano‐3, 11‐dioxo‐18β‐olean‐1, 12‐dien‐30‐oate in colon cancer cells S Chintharlapalli, S Papineni, M Abdelrahim, A Abudayyeh, I Jutooru, ... International journal of cancer 125 (8), 1965-1974, 2009 | 147 | 2009 |
| Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells M Abdelrahim, CH Baker, JL Abbruzzese, D Sheikh-Hamad, S Liu, ... Cancer research 67 (7), 3286-3294, 2007 | 144 | 2007 |
| Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors V Nair, S Sreevalsan, R Basha, M Abdelrahim, A Abudayyeh, AR Hoffman, ... Journal of Biological Chemistry 289 (40), 27692-27701, 2014 | 139 | 2014 |
| Targeting SP1 transcription factor in prostate cancer therapy U T Sankpal, S Goodison, M Abdelrahim, R Basha Medicinal chemistry 7 (5), 518-525, 2011 | 135 | 2011 |
| A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl … C Qin, D Morrow, J Stewart, K Spencer, W Porter, R Smith III, T Phillips, ... Molecular Cancer Therapeutics 3 (3), 247-260, 2004 | 134 | 2004 |
| Early experience with COVID-19 and solid organ transplantation at a US high-volume transplant center GY Stephanie, AW Rogers, A Saharia, M Aoun, R Faour, M Abdelrahim, ... Transplantation 104 (11), 2208-2214, 2020 | 126 | 2020 |
Stephen SafeProfessor of Toxicology, Texas A&M UniversityVerified email at cvm.tamu.edu
